TY - JOUR KW - Adult KW - Aged KW - England/epidemiology KW - Humans KW - *Influenza Vaccines KW - *Influenza, Human/prevention & control KW - *Pneumonia/epidemiology/prevention & control KW - Retrospective Studies KW - *Co-morbidities KW - *disease burden KW - *influenza KW - *pneumonia KW - *retrospective cohort study AU - D. Pokutnaya AU - M. Loiacono AU - H. Booth AU - R. Williams AU - C. Ma AU - J. Parker AU - H. Bricout AU - S. Farrow AU - J. Nealon AD - Department of Epidemiology, School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA. Global Medical Evidence Generation, Sanofi, Swiftwater, PA, USA. Clinical Practice Research Datalink (CPRD), Medicines and Healthcare Products Regulatory Agency, London, UK. UK/IE Medical Affairs, Sanofi, Reading, Berkshire, UK. Global Medical Evidence Generation, Sanofi, Lyon, France. School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China. AN - 35514148 BT - Epidemiol Infect DO - 10.1017/s0950268822000838 DP - NLM ET - 2022/05/07 LA - eng N1 - 1469-4409 Pokutnaya, Darya Loiacono, Matthew M Orcid: 0000-0001-8100-465x Booth, Helen Williams, Rachael Ma, Christopher Parker, James Bricout, Hélène Farrow, Susan Nealon, Joshua Journal Article Research Support, Non-U.S. Gov't England Epidemiol Infect. 2022 May 6;150:e107. doi: 10.1017/S0950268822000838. PY - 2022 SN - 0950-2688 EP - e107 T2 - Epidemiol Infect TI - The impact of clinical risk conditions on influenza and pneumonia diagnoses in England: a nationally representative retrospective cohort study, 2010-2019 VL - 150 ER -